Synthesis, Anti-Breast Cancer Activity, and Molecular Docking Study of a New Group of Acetylenic Quinolinesulfonamide Derivatives
作者:Krzysztof Marciniec、Bartosz Pawełczak、Małgorzata Latocha、Leszek Skrzypek、Małgorzata Maciążek-Jurczyk、Stanisław Boryczka
DOI:10.3390/molecules22020300
日期:——
regioisomeric acetylenic sulfamoylquinolines are designed, synthesized, and tested in vitro for their antiproliferative activity against three human breast cacer cell lines (T47D, MCF-7, and MDA-MB-231) and a human normal fibroblast (HFF-1) by 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate (WST-1) assay. The antiproliferative activity of the tested acetylenic quinolinesulfonamides
在这项研究中,设计,合成和测试了一系列区域异构的炔属氨磺酰基乙酰喹啉,它们对三种人类乳腺癌细胞系(T47D,MCF-7和MDA-MB-231)和人类正常成纤维细胞( HFF-1)通过4- [3-(4-碘苯基)-2-(4-硝基苯基)-2H-5-四唑基] -1,3-苯二磺酸盐(WST-1)测定。经测试的炔属喹啉磺酰胺类药物的抗增殖活性与顺铂相当。生物测定结果表明,大多数受试化合物均显示出有效的抗肿瘤活性,并且某些化合物对各种癌细胞系的显示优于阳性对照顺铂。在这些化合物中,4-(3-丙炔硫基)-7- [N-甲基-N-(3-丙炔基)氨磺酰基]喹啉对T47D细胞具有显着的抗增殖活性,IC50值为0.07 µM。另外,2-(3-丙炔硫基)-6- [N-甲基-N-(3-丙炔基)磺酰基-巯基]喹啉和2-(3-丙炔基硒代)-6- [N-甲基-N-(3 -丙炔基)氨基磺酰基]喹啉对MDA-MB-231细胞具有